Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Optimization of Variable Ventilation for Physiology, Immune Response and Surfactant Enhancement in Preterm Lambs.

Bartolák-Suki E, Noble PB, Bou Jawde S, Pillow JJ, Suki B.

Front Physiol. 2017 Jun 23;8:425. doi: 10.3389/fphys.2017.00425. eCollection 2017.

2.

Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.

Chun J, Sung SI, Ho YH, Kim J, Park GY, Yoon SA, Ahn SY, Chang YS, Park WS.

J Korean Med Sci. 2017 Aug;32(8):1288-1294. doi: 10.3346/jkms.2017.32.8.1288.

3.

The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Collins JJP, Tibboel D, de Kleer IM, Reiss IKM, Rottier RJ.

Front Med (Lausanne). 2017 May 22;4:61. doi: 10.3389/fmed.2017.00061. eCollection 2017. Review.

4.
5.

Meconium Aspiration Syndrome: An Insight.

Raju U, Sondhi V, Patnaik SK.

Med J Armed Forces India. 2010 Apr;66(2):152-7. doi: 10.1016/S0377-1237(10)80131-5. Epub 2011 Jul 21.

6.

Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.

Glaser K, Fehrholz M, Curstedt T, Kunzmann S, Speer CP.

PLoS One. 2016 Jan 20;11(1):e0146898. doi: 10.1371/journal.pone.0146898. eCollection 2016.

7.

Association of SCNN1A Single Nucleotide Polymorphisms with neonatal respiratory distress syndrome.

Li W, Long C, Renjun L, Zhangxue H, Yin H, Wanwei L, Juan M, Yuan S.

Sci Rep. 2015 Nov 27;5:17317. doi: 10.1038/srep17317.

8.

Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome.

Wang L, Chen L, Li R, Zhao J, Wu X, Li X, Shi Y.

Int J Clin Exp Med. 2015 Aug 15;8(8):13783-9. eCollection 2015.

9.

Environmental Pollutant Ozone Causes Damage to Lung Surfactant Protein B (SP-B).

Hemming JM, Hughes BR, Rennie AR, Tomas S, Campbell RA, Hughes AV, Arnold T, Botchway SW, Thompson KC.

Biochemistry. 2015 Aug 25;54(33):5185-97. doi: 10.1021/acs.biochem.5b00308. Epub 2015 Aug 13.

10.

Three-dimensional model of surfactant replacement therapy.

Filoche M, Tai CF, Grotberg JB.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9287-92. doi: 10.1073/pnas.1504025112. Epub 2015 Jul 13.

11.
12.
13.

A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome.

Rebello CM, Precioso AR, Mascaretti RS; Grupo Colaborativo do Estudo Brasileiro Multicêntrico de Surfactante.

Einstein (Sao Paulo). 2014 Oct-Dec;12(4):397-404. doi: 10.1590/S1679-45082014AO3095.

14.

Haemoglobin level at birth is associated with short term outcomes and mortality in preterm infants.

Banerjee J, Asamoah FK, Singhvi D, Kwan AW, Morris JK, Aladangady N.

BMC Med. 2015 Jan 27;13:16. doi: 10.1186/s12916-014-0247-6.

15.

Regulatory science needs for neonates: a call for neonatal community collaboration and innovation.

McCune SK, Mulugeta YA.

Front Pediatr. 2014 Dec 1;2:135. doi: 10.3389/fped.2014.00135. eCollection 2014. Review. No abstract available.

16.

Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea.

Kim SM, Park YJ, Chung SH, Choi YS, Kim CH, Bae CW.

J Korean Med Sci. 2014 Aug;29(8):1126-31. doi: 10.3346/jkms.2014.29.8.1126. Epub 2014 Jul 30.

17.

The challenge of understanding cerebral white matter injury in the premature infant.

Elitt CM, Rosenberg PA.

Neuroscience. 2014 Sep 12;276:216-38. doi: 10.1016/j.neuroscience.2014.04.038. Epub 2014 May 15. Review.

18.

Pilot observational study on haemodynamic changes after surfactant administration in preterm newborns with respiratory distress syndrome.

Vitali F, Galletti S, Aceti A, Aquilano G, Fabi M, Balducci A, Faldella G.

Ital J Pediatr. 2014 Mar 5;40(1):26. doi: 10.1186/1824-7288-40-26.

19.

Doxapram use for apnoea of prematurity in neonatal intensive care.

Prins SA, Pans SJ, van Weissenbruch MM, Walther FJ, Simons SH.

Int J Pediatr. 2013;2013:251047. doi: 10.1155/2013/251047. Epub 2013 Nov 26.

20.

Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Lopez E, Gascoin G, Flamant C, Merhi M, Tourneux P, Baud O; French Young Neonatologist Club.

BMC Pediatr. 2013 Oct 10;13:165. doi: 10.1186/1471-2431-13-165. Review.

Supplemental Content

Support Center